tert-Butyl ((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate

Catalog No. :
ACJKYR459
CAS No. :
1264243-41-5
Molecular Formula :
C10H20N2O3
Molecular Weight :
216.28

IUPAC Name:tert-butyl ((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate

tert-Butyl ((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$70.00Login to see priceIn stockInquiry
250mg97%$116.00Login to see priceIn stockInquiry
1g97%$303.00Login to see priceIn stockInquiry
5g97%$1060.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl ((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate
MDL No.MFCD08704528
Molecular FormulaC10H20N2O3
Molecular Weight216.28
SMILESO=C(OC(C)(C)C)N[C@H]1CN[C@H](CO)C1
InChI KeyDWYPGXBZFDWCPC-SFYZADRCSA-N
Synonym1217975-63-7 | TERT-BUTYL (3R,5S)-5-(HYDROXYMETHYL)PYRROLIDIN-3-YLCARBAMATE | 1264243-41-5 | tert-butyl ((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate | TERT-BUTYL N-[(3R,5S)-5-(HYDROXYMETHYL)PYRROLIDIN-3-YL]CARBAMATE | tert-Butyl ((3R,5S)-rel-5-(Hyd
CAS No.1264243-41-5
PubChem CID45072311

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJKYR459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJKYR459 route product structure diagram
    ACJKYR4591264243-41-5 In Stock
Inquiry

2. ACJKYR459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHUAM975 route compound structure diagram
    ACHUAM9751279034-98-8 In Stock
  2. Then
  3. ACJKYR459 route product structure diagram
    ACJKYR4591264243-41-5 In Stock
Inquiry

Comments (0)